Corvus Pharmaceuticals Inc Dividends
The next dividend date for Corvus Pharmaceuticals Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Corvus Pharmaceuticals Inc (CRVS)
More About Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States. The company's lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell atopic dermatitis, asthma, psoriasis, and fibrotic diseases. It also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer. It has a license agreement with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in South San Francisco, California.
Owning Corvus Pharmaceuticals Inc Stock on the Dividend Date
If you own Corvus Pharmaceuticals Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Corvus Pharmaceuticals Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Corvus Pharmaceuticals Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Corvus Pharmaceuticals Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Corvus Pharmaceuticals Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Corvus Pharmaceuticals Inc Dividends
You can contact us any time if you would like to ask questions about Corvus Pharmaceuticals Inc dividends or anything else related to the stock market.